VEGFA and neoplasm: The vasculature-normalizing effects of anti-VEGF therapy have also been shown to improve delivery of chemotherapeutic agents to tumor sites and enhance intratumoral immune cell infiltration, improving the efficacy of therapies like adoptive T-cell transfer [95, 96].